Cytolytics GmbH

Private

TübingenHealthcare & Life Scienceshttps://cytolytics.de/

Last Round

Grant

Oct 30, 2024

Total Funding Raised

$549,000

Company Overview

Cytolytics GmbH is a medical technology company that provides an AI-based cloud software platform for the automated analysis of flow cytometry data for researchers and healthcare professionals.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Healthcare Analytics, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

flow cytometryflow cytometry analysisbioinformaticscytometry softwareautomated data analysisbioinformatics toolsmachine learningdata visualizationvertical SaaSclinical diagnosticsdimensionality reductionbiotech softwarelab automationbioinformatics consultingsingle cell analysis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cytolytics GmbH Comps

Public and private peers based on sector, stage, and business model.

Cytolytics GmbH comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Cytolytics GmbH Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Oct 30, 2024
Grant	Sep 30, 2024
Pre Seed	Aug 16, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Serina Pinar

Founder l Chief Operating Officer, Founder l Chief Strategy Officer

Founding Team

Can Pinar

Founder and CEO

Founding Team

Cytolytics GmbH Investors

Notable investors and investment history

Cytolytics GmbH investors
Investor	Rounds
Invest BW Innovationsförderung	Grant
State of Baden-Württemberg	Grant
L-Bank	Pre Seed

View all Investors

Cytolytics GmbH Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Cytolytics GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cytolytics GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersTübingen

Employee Range7

Year Founded2020

Last FundingOct 30, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.